Bullock Wealth Management’s Boston Scientific BSX Stock Holding History

Bullock Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.43K	Sell	126 -2,481	-95%	-$135K	﹤0.01%	498
2026 Q1	$162K	Sell	2,607 -162	-6%	-$13K	0.08%	183
2025 Q4	$264K	Sell	2,769 -765	-22%	-$75K	0.13%	140
2025 Q3	$339K	Sell	3,534 -11	-0.3%	-$1.14K	0.17%	113
2025 Q2	$371K	Buy	3,545 +24	+0.7%	+$2.43K	0.2%	106
2025 Q1	$356K	Buy	3,521 +1,516	+76%	+$153K	0.2%	106
2024 Q4	$179K	Buy	+2,005	New	+$177K	0.1%	161

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bullock Wealth Management's BSX Position: Q2 2026 in Review

Bullock Wealth Management reduced its Boston Scientific (BSX) stake by 95% in Q2 2026, selling an estimated $135K and leaving 126 shares worth $5.43K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Bullock Wealth Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $371K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Bullock Wealth Management held 126 shares of Boston Scientific worth $5.43K as of Q2 2026.
Bullock Wealth Management sold 2,481 Boston Scientific shares in Q2 2026, an estimated $135K.
Boston Scientific made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #498 holding.
Bullock Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Bullock Wealth Management's Boston Scientific position peaked at $371K in Q2 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.